Navigation Links
Considerably more patients may benefit from effective antidiabetic drug
Date:9/17/2012

The antidiabetic drug metformin is not prescribed for patients with reduced kidney function because the risk of adverse effects has been regarded as unacceptably high. A study at Sahlgrenska Academy, University of Gothenburg, Sweden, has found that the risks have been substantially overrated. As a result, many more patients with diabetes may be able to enjoy the benefits of the medication.

Type 2 diabetes, a very common condition, is increasingly prevalent around the world. Keeping diabetes under control and preventing complications requires not only lifestyle changes, but drug therapy to reduce blood glucose levels.

Among the most effective and frequently prescribed antidiabetics is metformin, which has been shown in a number of studies to lower the risk of death from cardiovascular disease. Because the drug has been considered causing an increased risk of developing a rare but life-threatening adverse effect known as lactic acidosis, it is not prescribed for patients with reduced kidney function.

Researchers at Sahlgrenska Academy, University of Gothenburg and Uppsala University have conducted a study involving 51,700 patients with type 2 diabetes from the Swedish national diabetes register and found that the risks are exaggerated.

The Gothenburg study shows that metformin is more effective than other glucose lowering drugs when it comes to reducing the risk of cardiovascular disease, serious infection and death in patients with normal kidney function, but also in patients with mild kidney impairment.

"Furthermore, patients with mild to moderate kidney impairment do not run an elevated risk of adverse effects from metformin,"says Nils Ekstrm, a researcher at Sahlgrenska Academy. "Thus, the drug can be prescribed for many more patients with diabetes than is currently the case."

According to Nils Ekstrm, a number of other countries already recommend metformin for patients with mild kidney impairment. "It is important to keep in mind that the results are for patients with mild to moderate kidney impairment," he says. "Metformin still cannot be recommended for patients with severe kidney impairment and should be prescribed with great caution for those patients. During periods of acute illness with dehydration, metformin should never be used"


'/>"/>

Contact: Nils Ekstrm
nils.ekstrom@gu.se
46-702-890-121
University of Gothenburg
Source:Eurekalert

Related medicine news :

1. Sound level around seriously ill patients like a busy road
2. Simple tool may help evaluate risk for violence among patients with mental illness
3. Study: Gingko biloba does not improve cognition in MS patients
4. Cystic fibrosis patients of low SES are less likely to be accepted for lung transplant
5. Perceived control affects complication rates in patients with acute coronary syndrome
6. Physicians suggest expert recommendations ignore vital issues for patients
7. Docs Sensitivity to Patients Feelings Tied to Good Outcomes
8. Technique using CT linked with improved detection of lymph node metastasis in patients with melanoma
9. Tight blood sugar control for pediatric cardiac surgery patients does not improve outcomes
10. No proof that patients lose weight after joint replacement surgery
11. Language Barrier Hurts Elderly Asthma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... ... During the last week of March, Chad Kawa, MD of Revere Health ... local community. , Colon cancer is the second leading cause of cancer deaths ... is small, confined and easier to treat. If you are 50 or older, colonoscopies ...
(Date:3/29/2017)... ... March 29, 2017 , ... ARI Network Services, Inc. (NASDAQ: ARIS) announced ... dealer websites for its network of more than 650 U.S.-based dealers. Rhino, a member ... including rotary and flail mowers and cutters, rear blades, post hole diggers, pasture renovators, ...
(Date:3/29/2017)... ... March 29, 2017 , ... In the United States alone, up to 36% ... other types of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain tumors ... finding more effective treatment options, the San Diego Gamma Knife Center offers ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... professional squash, announced it has enlisted New York City-based sports and entertainment marketing ... develop and procure sponsorship opportunities for the Professional Squash Association (PSA), which includes ...
(Date:3/29/2017)... ... ... Full Contact K9, an Atlanta-based dog services provider, has recently teamed up ... owners in creating legally-enforceable pet trusts for their canine companions. , Therilus, a ... their new companion. Says Evan Dunbar, CEO of Full Contact K9, “When our clients ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Mar. 29, 2017 Research and Markets ... Market Size & Forecast By Type (Insource IONM, Outsource IONM), ... report to their offering. ... The global Intraoperative Neuromonitoring (IONM) market ... intraoperative neuromonitoring market is anticipated to witness significant growth in ...
(Date:3/29/2017)... , March 29, 2017  Bodycad announced today ... Administration (FDA) 510(k) clearance for its Bodycad Unicompartmental ... truly personalized orthopaedic restoration. Bodycad is the first ... joint reconstruction implant system. Bodycad,s ... personalized restoration of the patient,s unique anatomical features ...
(Date:3/29/2017)... , March 29, 2017 Wound care ... promote healing of the wound. The industry mainly consists ... products for the treatment of wounds caused by mechanical, ... due to diseases such as diabetes, skin related diseases, ... Europe was the largest region in ...
Breaking Medicine Technology: